Technology explainer
How Can a Genetically Modified Pig Kidney Work in a Human?
Pig kidneys are biologically similar to human kidneys, but immune incompatibility, clotting and infection risks prevent ordinary transplantation. Gene editing removes key barriers, adds protective human proteins and disables viral sequences, while powerful medicines and close monitoring remain essential.
Pig kidneys are close enough to human kidneys in size and basic function to filter blood and make urine, but an unmodified pig organ would face an immediate and destructive immune attack in a person. Modern xenotransplantation tries to change both sides of that encounter: researchers edit the donor pig, and doctors carefully control the recipient's immune response.
Removing the fastest immune triggers
Human antibodies recognize several sugars and proteins on pig cells as foreign. Binding to those targets can activate complement, a powerful immune cascade, and destroy the organ's blood vessels within minutes or hours. Researchers therefore remove pig genes that produce the most dangerous molecular targets. This lowers the risk of hyperacute rejection, but it does not make the organ invisible to immunity.
Adding protective human genes
Other edits add human genes that help regulate complement, inflammation and blood clotting. This matters because a transplanted kidney depends on thousands of tiny vessels. Even when immediate rejection is prevented, incompatibilities between pig and human clotting systems can damage these vessels and reduce the graft's function over time.
Reducing viral risk
Pig DNA contains porcine endogenous retroviruses, or PERVs. These sequences are inherited parts of the pig genome rather than ordinary infections acquired from another animal. Scientists can disable many PERV copies with gene editing. Recipients are also tested repeatedly for evidence of pig pathogens because no edit can replace long-term surveillance.
Medicines still do much of the work
A gene-edited organ still requires immunosuppressive treatment. The drug combination may target immune pathways involved in antibody production, T cells and inflammation. Clinicians track kidney filtration, urine production, antibodies, infections and tissue changes through blood tests and biopsies. Treatment can be adjusted when signs of immune injury appear, although stronger suppression can also raise infection risk.
What success would mean
A pig kidney might eventually serve as a temporary bridge while a patient waits for a human donor, or as a longer-lasting treatment if durability improves. A functioning organ in one person proves biological possibility, not routine safety. Larger clinical trials must determine typical survival, complications, cost and which patients gain more from xenotransplantation than from remaining on dialysis.
First appeared in
A Pig Kidney Kept a Man Off Dialysis for 271 Days